Janice Kwon

Janice Kwon

UNVERIFIED PROFILE

Are you Janice Kwon?   Register this Author

Register author
Janice Kwon

Janice Kwon

Publications by authors named "Janice Kwon"

Are you Janice Kwon?   Register this Author

70Publications

1278Reads

15Profile Views

Examining indicators of early menopause following opportunistic salpingectomy: A cohort study from British Columbia, Canada.

Am J Obstet Gynecol 2020 Feb 14. Epub 2020 Feb 14.

Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University of British Columbia, Vancouver BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2020.02.005DOI Listing
February 2020

Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment.

Authors:
Janice S Kwon

J Gynecol Oncol 2019 09;30(5):e92

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3802/jgo.2019.30.e92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658603PMC
September 2019

Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.

Gynecol Oncol 2019 07 15;154(1):124-130. Epub 2019 May 15.

Department Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.097DOI Listing
July 2019

BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.

Gynecol Oncol 2019 03;152(3):459-464

Hereditary Cancer Program, BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.10.014DOI Listing
March 2019

Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study.

Int J Gynecol Cancer 2018 10;28(8):1624-1630

Department of Laboratory Medicine and Pathology, Lions Gate Hospital, North Vancouver.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001343DOI Listing
October 2018

Does MMR status in endometrial cancer influence response to adjuvant therapy?

Gynecol Oncol 2018 10 29;151(1):76-81. Epub 2018 Aug 29.

BC Cancer Agency, Vancouver, BC, Canada; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183115
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.08.020DOI Listing
October 2018

Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.

Am J Obstet Gynecol 2018 08 28;219(2):172.e1-172.e8. Epub 2018 May 28.

Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, University of British Columbia, Vancouver BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2018.05.019DOI Listing
August 2018

Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.

J Obstet Gynaecol Can 2018 Mar 3;40(3):328-333. Epub 2017 Oct 3.

BC Cancer Agency, Vancouver, BC; Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2017.06.037DOI Listing
March 2018

Cost-effectiveness of Ovarian Cancer Prevention Strategies.

Authors:
Janice S Kwon

Clin Obstet Gynecol 2017 12;60(4):780-788

Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0000000000000317DOI Listing
December 2017

Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer.

J Natl Compr Canc Netw 2017 08;15(8):1015-1021

Department of Obstetrics and Gynecology, Division of Surgical Oncology, University of British Columbia, and BC Cancer Agency, Vancouver, British Columbia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0136DOI Listing
August 2017

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

J Clin Oncol 2017 Jul 11;35(20):2329-2337. Epub 2017 Apr 11.

Goli Samimi, Charlisse F. Caga-anan, Michael Dean, Leah E. Mechanic, Lori M. Minasian, and Mark E. Sherman, National Cancer Institute; Lawrence C. Brody, National Human Genome Research Institute, Bethesda, MD; Marcus Q. Bernardini, Stephanie Lheureux, Patricia A. Shaw, Princess Margaret Cancer Centre, Toronto, Ontario; Janice S. Kwon, University of British Columbia; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Ian G. Campbell, Paul A. James, Masataka Takenaka, and David D. Bowtell, Peter MacCallum Cancer Centre; David D. Bowtell, University of Melbourne, Melbourne, Victoria; Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Michael Friedlander, The Prince of Wales Hospital; Susan J. Ramus, University of New South Wales; Susan J. Ramus and David D. Bowtell, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Fergus J. Couch, Mayo Clinic, Rochester, MN; Joanne A. de Hullu and Marline G. Harmsen, Radboud University Medical Center, Nijmegen, the Netherlands; Susan M. Domchek and Ronny Drapkin, University of Pennsylvania, Philadelphia; Phuong L. Mai, Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Heather Spencer Feigelson, Kaiser Permanente Institute for Health Research, Denver, CO; Mia M. Gaudet, American Cancer Society, Atlanta, GA; Karen Hurley and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mark E. Robson, Weill Cornell Medical College, New York, NY; Felicitas Lacbawan, Quest Diagnostics Nichols Institute, San Juan Capistrano; Thomas P. Slavin, City of Hope, Duarte, CA; Evan R. Myers, Duke University Medical Center, Durham, NC; Lisa F. Rezende, FORCE: Facing Our Risk of Cancer Empowered, Tampa; Mark E. Sherman, Mayo Clinic, Jacksonville, FL; and Elizabeth M. Swisher, University of Washington Medical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501360PMC
July 2017

Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.

Cancer Treat Rev 2017 Apr 22;55:26-35. Epub 2017 Feb 22.

Departments of Obstetrics and Gynecology and Surgical Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.02.005DOI Listing
April 2017

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.

Cancer 2017 03 6;123(5):802-813. Epub 2017 Jan 6.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30496DOI Listing
March 2017

Improved Outcome of High-Grade, Early 1-Stage Endometrioid Endometrial Carcinoma With Adjuvant Chemotherapy and Radiotherapy: Comparison of 2 Treatment Strategies.

Int J Gynecol Cancer 2017 03;27(3):467-472

*Department of Obstetrics and Gynaecology, Elisabeth-TweeSteden Hospital, Tilburg; †Division of Woman and Baby, University Medical Centre Utrecht, The Netherlands; ‡Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Vancouver, Canada; §Comprehensive Cancer Centre The Netherlands, Eindhoven; and ∥Centre of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000900DOI Listing
March 2017

Diabetic Pharmacotherapy and Endometrial Cancer Risk Within a Publicly Funded Health Care System.

J Obstet Gynaecol Can 2017 Jan 4;39(1):42-48. Epub 2016 Dec 4.

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2016.09.078DOI Listing
January 2017

BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.

Int J Gynecol Cancer 2016 06;26(5):825-32

Departments of *Obstetrics and Gynecology, and †Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; ‡Faculty of Medicine, Universiteit van Amsterdam, Amsterdam, the Netherlands; §Department of Pathology and Laboratory Medicine, BC Cancer Agency; ∥Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia; ¶Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Toronto, Ontario; and #Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000698DOI Listing
June 2016

Long-term consequences of ovarian ablation for premenopausal breast cancer.

Breast Cancer Res Treat 2016 06 28;157(3):565-73. Epub 2016 May 28.

Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3842-8DOI Listing
June 2016

Opportunistic salpingectomy for ovarian cancer prevention.

Gynecol Oncol Res Pract 2015 17;2. Epub 2015 Sep 17.

Hereditary Cancer Program, BC Cancer Agency, Vancouver, BC Canada ; Department of Medicine, University of British Columbia, Vancouver, BC Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-015-0014-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881168PMC
May 2016

Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectives.

Gynecol Oncol 2016 Jan 6;140(1):83-9. Epub 2015 Nov 6.

Department of Obstetrics and Gynecology, Seoul National University, College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.11.007DOI Listing
January 2016

Improving survival after endometrial cancer: the big picture.

Authors:
Janice S Kwon

J Gynecol Oncol 2015 Jul;26(3):227-31

Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3802/jgo.2015.26.3.227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510340PMC
July 2015

Ovarian cancer risk reduction through opportunistic salpingectomy.

Authors:
Janice S Kwon

J Gynecol Oncol 2015 Apr;26(2):83-6

Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3802/jgo.2015.26.2.83DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397236PMC
April 2015

Peritoneal tuberculosis presenting as persistent ascites.

J Obstet Gynaecol Can 2015 Apr;37(4):295

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver BC; Division of Gynaecologic Oncology, University of British Columbia, Vancouver BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(15)30274-7DOI Listing
April 2015

Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.

Obstet Gynecol 2015 Feb;125(2):338-45

Division of Gynecologic Oncology, University of British Columbia and OVCARE, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000000630DOI Listing
February 2015

The role of palliative colorectal stents in gynaecologic malignancy.

Gynecol Oncol 2014 Sep 28;134(3):566-9. Epub 2014 Jun 28.

Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Diamond Health Care Centre, 2775 Laurel Street, Vancouver, British Columbia V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.06.020DOI Listing
September 2014

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Am J Surg Pathol 2014 Sep;38(9):1173-81

Departments of *Laboratory Medicine and Pathobiology ‡Obstetrics and Gynecology, Faculty of Medicine, University of Toronto §Division of Gynecologic Oncology §§Department of Pathology, University Health Network ∥Department of Laboratory Medicine and Pathology ¶Zane Cohen Centre for Digestive Diseases, Familial Gastrointestinal Cancer Registry ‡‡Division of General Surgery, Mount Sinai Hospital, Toronto, ON ∥∥Department of Medical Genetics, McGill University Health Centre, Montreal, QB #Division of Gynecologic Oncology ¶¶Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada †Department of Pathology, Bon Secours Hospital, Cork, Ireland **Department of Histopathology, King Edward Memorial Hospital for Women, Perth, Australia ††Department of Cellular Pathology, Barts Health NHS Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/09000/The_Histomorpho
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000298DOI Listing
September 2014

The significance of combination chemotherapy in epithelial ovarian cancer.

Int J Gynecol Cancer 2014 Feb;24(2):226-32

*Division of Gynecologic Oncology, University of British Columbia; †Cancer Surveillance and Outcomes, Population Oncology, BC Cancer Agency; ‡Department of Obstetrics and Gynecology, University of British Columbia; and §Cheryl Brown Ovarian Cancer Outcomes Unit, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000055DOI Listing
February 2014

Population-based treatment and outcomes of Stage I uterine serous carcinoma.

Gynecol Oncol 2014 Jan 9;132(1):61-4. Epub 2013 Nov 9.

Division of Gynecologic Oncology, BC Cancer Agency, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.002DOI Listing
January 2014

The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.

Gynecol Oncol 2013 Dec 19;131(3):581-5. Epub 2013 Sep 19.

Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Diamond Health Care Centre, 2775 Laurel Street, Vancouver, British Columbia V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.09.012DOI Listing
December 2013

Preoperative radiotherapy for inoperable stage II endometrial cancer: insights into improving treatment and outcomes.

J Obstet Gynaecol Can 2013 Jul;35(7):635-639

Division of Gynaecologic Oncology, University of British Columbia and BC Cancer Agency, Vancouver BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(15)30893-8DOI Listing
July 2013

Penile carcinoma: lessons learned from vulvar carcinoma.

J Urol 2013 Jan 16;189(1):17-24. Epub 2012 Nov 16.

Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.08.082DOI Listing
January 2013

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

Obstet Gynecol 2013 Jan;121(1):14-24

University of British Columbia and BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/aog.0b013e3182783c2fDOI Listing
January 2013

New insights into the pathogenesis of ovarian carcinoma: time to rethink ovarian cancer screening.

Obstet Gynecol 2012 Oct;120(4):935-40

British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e318269b8b1DOI Listing
October 2012

Cancer screening practices of cancer survivors: population-based, longitudinal study.

Can Fam Physician 2012 Sep;58(9):980-6

Department of Family and Community Medicine, University of Toronto, 500 University Ave, Room 352, Toronto, ON M5G 1V7.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440276PMC
September 2012

The significance of surgical staging in intermediate-risk endometrial cancer.

Gynecol Oncol 2011 Jul 21;122(1):50-4. Epub 2011 Mar 21.

Division of Gynecologic Oncology, University of British Columbia and BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.02.037DOI Listing
July 2011

Testing women with endometrial cancer to detect Lynch syndrome.

J Clin Oncol 2011 Jun 2;29(16):2247-52. Epub 2011 May 2.

University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.9979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874206PMC
June 2011

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.

J Pathol 2011 Apr 7;223(5):567-73. Epub 2011 Mar 7.

Department of Pathology and Laboratory Medicine, University of British Columbia, British Columbia Cancer Agency, 3427-600 West 10th Avenue, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2848DOI Listing
April 2011

Expanding the criteria for BRCA mutation testing in breast cancer survivors.

J Clin Oncol 2010 Sep 23;28(27):4214-20. Epub 2010 Aug 23.

Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.0719DOI Listing
September 2010

Preventing future cancers by testing women with ovarian cancer for BRCA mutations.

J Clin Oncol 2010 Feb 19;28(4):675-82. Epub 2009 Oct 19.

Division of Gynecologic Oncology, University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.4684DOI Listing
February 2010

Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer?

Obstet Gynecol 2009 Oct;114(4):736-43

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e3181b96ec6DOI Listing
October 2009

Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.

Gynecol Oncol 2009 Jul 29;114(1):94-8. Epub 2009 Apr 29.

Department of Radiation Oncology, University of Western Ontario, London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital, 790 Commissioners Road East, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.03.027DOI Listing
July 2009

Secondary cancer prevention during follow-up for endometrial cancer.

Obstet Gynecol 2009 Apr;113(4):790-5

Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e31819c842dDOI Listing
April 2009

Should preoperative pathology be used to select patients for surgical staging in endometrial cancer?

Int J Gynecol Cancer 2009 Apr;19(3):380-4

Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181a1a657DOI Listing
April 2009

Are there regional differences in gynecologic cancer outcomes in the context of a single-payer, publicly-funded health care system? A population-based study.

Can J Public Health 2008 May-Jun;99(3):221-6

Division of Gynecologic Oncology, University of British Columbia and BC Cancer Agency, Vancouver, BC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975767PMC
August 2008

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.

Cancer 2008 Jul;113(2):326-35

Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23554DOI Listing
July 2008

Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.

Obstet Gynecol 2008 Jul;112(1):56-63

Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/AOG.0b013e31817d53a4DOI Listing
July 2008

Addressing wait times for endometrial cancer surgery in Ontario.

J Obstet Gynaecol Can 2007 Dec;29(12):982-987

Department of Health Services Research, Institute for Clinical Evaluative Sciences, Toronto ON.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(16)32691-3DOI Listing
December 2007

When is a pathology review indicated in endometrial cancer?

Obstet Gynecol 2007 Dec;110(6):1224-30

Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/01.AOG.0000287618.86078.6cDOI Listing
December 2007

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.

Cancer 2007 Feb;109(4):692-702

Department of Obstetrics and Gynecology, Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22466
Publisher Site
http://dx.doi.org/10.1002/cncr.22466DOI Listing
February 2007

Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer.

J Obstet Gynaecol Can 2007 Feb;29(2):131-139

Department of Health Policy and Management, Harvard School of Public Health, Boston MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(16)32387-8DOI Listing
February 2007

Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.

Int J Radiat Oncol Biol Phys 2007 Jan 2;67(1):110-6. Epub 2006 Nov 2.

Department of Radiation Oncology, University of Western Ontario and London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160602743
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2006.08.006DOI Listing
January 2007

Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review.

Gynecol Oncol 2006 Aug 2;102(2):361-8. Epub 2006 May 2.

Juravinski Regional Cancer Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.03.008DOI Listing
August 2006

Sentinel node mapping with isosulfan blue dye in endometrial cancer.

J Obstet Gynaecol Can 2005 Dec;27(12):1107-12

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, London Health Sciences Centre, University of Western Ontario, London, ON.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)30393-0DOI Listing
December 2005

A comparison of endometrial cancer outcomes in Ontario.

J Obstet Gynaecol Can 2004 Sep;26(9):793-8

Division of Gynaecologic Oncology, University of Western Ontario, London ON, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)30150-5DOI Listing
September 2004

The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma.

Int J Radiat Oncol Biol Phys 2004 Aug;59(5):1439-45

Division of Gynecologic Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.01.044DOI Listing
August 2004

Brain metastases from endometrial carcinoma: a retrospective study.

Gynecol Oncol 2004 May;93(2):524-8

Department of Obstetrics and Gynecology, London Health Sciences Centre, University of Western Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.02.006DOI Listing
May 2004

Effects of cancer treatment on reproduction and fertility.

J Obstet Gynaecol Can 2002 Aug;24(8):619-27

Department of Obstetrics and Gynecology, University of Western Ontario, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)30192-xDOI Listing
August 2002

A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel.

Gynecol Oncol 2002 Mar;84(3):420-5

Division of Gynecologic Oncology, University of Toronto, Toronto, Ontario, M5S 1A1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/gyno.2001.6546DOI Listing
March 2002